首页> 外文会议>SPIE Medical Imaging Conference >Quantitative Assessment of the Relationship Between Myocardial Lesion Formation Detected by Delayed Contrast-Enhanced Magnetic Resonance Imaging and Proton Beam Planning Dose for Treatment of Ventricular Tachycardia
【24h】

Quantitative Assessment of the Relationship Between Myocardial Lesion Formation Detected by Delayed Contrast-Enhanced Magnetic Resonance Imaging and Proton Beam Planning Dose for Treatment of Ventricular Tachycardia

机译:延迟对比度增强磁共振成像检测与质子束规划剂量检测的心肌病变形成关系的定量评估治疗心室性心动过缓

获取原文

摘要

Proton beam therapy has recently been proposed as a noninvasive approach for treating ventricular tachycardia(VT), where target regions are identified in the myocardium and treated using external beam therapy. Effectivetreatment requires that lesions develop at target sites of myocardial tissue in order to stop arrhythmic pathways.Precise characterization of the dose required for lesion creation is required for determining appropriate doselevels in future clinical treatement of VT patients. In this work, we use a deformable registration algorithm toalign proton beam delivery isodose lines planned from baseline computed-tomography scans to follow-up delayedcontrast-enhanced magnetic resonance imaging scans in three swine studies. The relationship between myocardiallesion formation and delivered dose from external proton beam ablation therapy is then quantitatively assessed.The current study demonstrates that myocardial tissue receiving a dose of 20Gy or higher tends to develop intolesion, while tissue exposed to less than 10Gy of dose tends to remain healthy. Overall, this study quantifies therelationship between external proton beam therapy dose and myocardial lesion formation which is important fordetermining dose levels in future clinical treatment of VT patients.
机译:最近已经提出了质子束治疗作为治疗心室性心动过速的非侵入性方法(vt),其中靶区域在心肌中鉴定并使用外部光束疗法治疗。有效的治疗要求病变在心肌组织的靶位部位开发,以阻止心律失常途径。确定病变创造所需剂量的精确表征,用于确定合适的剂量VT患者未来临床治疗中的水平。在这项工作中,我们使用可变形的登记算法对准质子束递送体探模线从基线计算断层扫描扫描到后续延迟三种猪研究中的对比度增强的磁共振成像扫描。心肌之间的关系然后定量评估来自外部质子束消融疗法的病变形成和递送剂量。目前的研究表明,接受20Gy或更高剂量的心肌组织倾向于发展病变,而细胞暴露于10Gy剂量的组织往往保持健康。总的来说,这项研究量化了外部质子束治疗剂量与心肌病变形成的关系测定VT患者未来临床治疗中的剂量水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号